| Style | Citing Format |
|---|---|
| MLA | Rezaei N, Keshavarzfathi M. "Preface." Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives, vol. , no. , 2019, pp. xiii-xiii. |
| APA | Rezaei N, Keshavarzfathi M (2019). Preface. Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives, (), xiii-xiii. |
| Chicago | Rezaei N, Keshavarzfathi M. "Preface." Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives , no. (2019): xiii-xiii. |
| Harvard | Rezaei N, Keshavarzfathi M (2019) 'Preface', Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives, (), pp. xiii-xiii. |
| Vancouver | Rezaei N, Keshavarzfathi M. Preface. Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives. 2019;():xiii-xiii. |
| BibTex | @article{ author = {Rezaei N and Keshavarzfathi M}, title = {Preface}, journal = {Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives}, volume = {}, number = {}, pages = {xiii-xiii}, year = {2019} } |
| RIS | TY - JOUR AU - Rezaei N AU - Keshavarzfathi M TI - Preface JO - Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives VL - IS - SP - xiii EP - xiii PY - 2019 ER - |